1857

COM:CKDPHARM

종근당

  • Stock

Last Close

101.60K

12/11 06:30

Market Cap

1.36T

Beta: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
4.42B
-
35.15B
695.88%
-6.77B
119.27%
40.95B
704.57%
53.73B
31.22%
41.70B
22.38%
52.98B
27.03%
90.40B
70.65%
42.36B
53.15%
79.98B
88.82%
212.52B
165.73%
depreciation and amortization
3.28B
-
20.55B
526.38%
22.68B
10.36%
23.93B
5.54%
21.99B
8.14%
21.22B
3.49%
23.05B
8.65%
23.79B
3.18%
27.48B
15.54%
33.60B
22.25%
36.94B
9.95%
deferred income tax
stock based compensation
change in working capital
426.33M
-
-5.96B
1,498.68%
-26.70B
347.78%
-36.18B
35.48%
-21.60B
40.30%
-41.44B
91.85%
-21.55B
47.98%
-51.48B
138.85%
-71.57B
39.01%
-77.30B
8.01%
29.68B
138.40%
accounts receivables
10.83B
-
-21.89B
302.11%
-6.93B
68.37%
-51.44B
642.65%
-29.56B
42.53%
inventory
4.00B
-
-5.93B
248.21%
-19.50B
229.09%
-17.64B
9.56%
-19.59B
11.04%
-30.80B
57.26%
-48.85B
58.57%
-46.24B
5.33%
-53.77B
16.29%
-54.47B
1.29%
-5.98B
89.02%
accounts payables
33.40B
-
42.36B
26.82%
-15.60B
136.82%
15.82B
201.45%
38.58B
143.82%
other working capital
-3.57B
-
-36.20M
98.99%
-7.20B
19,783.50%
-18.54B
157.57%
-2.01B
89.15%
-10.64B
428.68%
-16.94B
59.31%
-25.71B
51.73%
4.73B
118.38%
12.78B
170.40%
26.64B
108.46%
other non cash items
1.84B
-
14.85B
708.95%
18.07B
21.66%
29.08B
60.96%
27.56B
5.24%
21.14B
23.28%
22.82B
7.92%
41.62B
82.39%
14.63B
64.84%
31.46B
114.96%
39.01B
24.02%
net cash provided by operating activities
9.96B
-
64.59B
548.52%
7.27B
88.74%
57.79B
694.64%
81.67B
41.34%
42.63B
47.81%
77.29B
81.32%
104.32B
34.98%
12.90B
87.63%
67.73B
424.92%
318.16B
369.72%
investments in property plant and equipment
-2.12B
-
-21.32B
906.41%
-35.67B
67.29%
-39.44B
10.56%
-21.32B
45.94%
-24.64B
15.56%
-24.86B
0.90%
-36.82B
48.09%
-51.84B
40.81%
-53.06B
2.35%
-68.81B
29.66%
acquisitions net
-2.50B
-
-2.10B
16.12%
-3.08B
46.73%
71.62M
102.33%
-2.69B
-
-4.11B
52.75%
-3.45B
16.09%
142.13M
104.12%
451.58M
217.72%
purchases of investments
-447.66M
-
-7.99B
1,685.43%
-1.66B
79.18%
-1.15B
31.02%
-20.24B
1,663.64%
-6.20B
69.35%
-17.05B
174.84%
-59.96B
251.62%
-61.27B
2.18%
-57.18B
6.67%
-192.47B
236.59%
sales maturities of investments
3.44B
-
3.10B
10%
-1.21B
138.95%
17.03B
1,512.34%
1.80B
-
32.52B
1,706.47%
21.93B
32.54%
44.38B
102.31%
85.15B
91.88%
other investing activites
175.09M
-
2.59B
1,378.09%
407.62M
84.25%
1.47B
261.04%
579.55M
60.62%
509.43M
12.10%
3.08B
504.09%
4.45B
44.50%
3.82B
14.20%
347.81M
90.88%
39.75M
88.57%
net cash used for investing activites
-2.39B
-
-25.79B
978.37%
-35.93B
39.33%
-43.40B
20.78%
-23.88B
44.97%
-30.33B
27.03%
-39.73B
30.96%
-63.92B
60.90%
-90.81B
42.06%
-65.38B
28.00%
-175.64B
168.64%
debt repayment
-1.60B
-
-10B
525%
-77.50B
675%
-43.47B
43.91%
-75.04B
72.63%
-11.83B
84.23%
-61.97B
423.75%
-896.23M
98.55%
-263.14K
99.97%
-22.71B
8,632,034.99%
common stock issued
1.36B
-
-3.34B
-
common stock repurchased
-383.62M
-
-6.95B
-
-442.89M
93.63%
-2.08B
369.20%
-1.94B
6.87%
-1.89B
2.42%
-1.70B
9.91%
dividends paid
-2.82B
-
-7.52B
166.67%
-5.64B
25%
-8.46B
50%
-8.46B
0%
-8.84B
4.44%
-9.28B
4.96%
-10.81B
16.50%
-11.24B
3.98%
-11.61B
3.29%
other financing activites
1.60B
-
10B
525.00%
77.50B
675%
17.20B
77.81%
77.35B
349.76%
14.53B
81.22%
80.39B
453.46%
98.78B
22.87%
-3.21B
103.25%
-16.53M
99.49%
net cash used provided by financing activities
-383.62M
-
-2.82B
635.40%
-7.52B
166.67%
-5.64B
25%
-34.73B
515.56%
-11.74B
66.21%
-6.59B
43.87%
7.07B
207.30%
85.14B
1,104.43%
-16.34B
119.19%
-39.38B
140.98%
effect of forex changes on cash
-17.22M
-
-366.80M
2,030.52%
262.99M
171.70%
121.81M
53.68%
689.29M
465.89%
-78.29M
111.36%
-1.89M
97.59%
-734.87M
38,827.16%
920.10M
225.21%
-410.12M
144.57%
-917.57M
123.73%
net change in cash
7.17B
-
35.61B
396.89%
-35.92B
200.85%
8.87B
124.69%
23.75B
167.83%
477.48M
97.99%
30.97B
6,386.96%
46.74B
50.89%
8.15B
82.55%
-14.40B
276.56%
102.23B
810.13%
cash at beginning of period
5.99B
-
13.16B
119.67%
48.77B
270.69%
12.85B
73.65%
21.72B
68.99%
45.47B
109.34%
45.95B
1.05%
76.92B
67.41%
123.66B
60.76%
131.81B
6.59%
117.42B
10.92%
cash at end of period
13.16B
-
48.77B
270.69%
12.85B
73.65%
21.72B
68.99%
45.47B
109.34%
45.95B
1.05%
76.92B
67.41%
123.66B
60.76%
131.81B
6.59%
117.42B
10.92%
219.65B
87.07%
operating cash flow
9.96B
-
64.59B
548.52%
7.27B
88.74%
57.79B
694.64%
81.67B
41.34%
42.63B
47.81%
77.29B
81.32%
104.32B
34.98%
12.90B
87.63%
67.73B
424.92%
318.16B
369.72%
capital expenditure
-2.12B
-
-21.32B
906.41%
-35.67B
67.29%
-39.44B
10.56%
-21.32B
45.94%
-24.64B
15.56%
-24.86B
0.90%
-36.82B
48.09%
-51.84B
40.81%
-53.06B
2.35%
-68.81B
29.66%
free cash flow
7.84B
-
43.27B
451.81%
-28.40B
165.64%
18.35B
164.60%
60.35B
228.95%
17.99B
70.19%
52.43B
191.47%
67.51B
28.76%
-38.94B
157.68%
14.67B
137.67%
249.35B
1,599.78%

All numbers in (except ratios and percentages)